Literature DB >> 29590340

Exercise cardiac magnetic resonance to differentiate athlete's heart from structural heart disease.

Guido Claessen1,2, Frédéric Schnell1,3, Jan Bogaert2,4, Mathias Claeys1,2, Nele Pattyn5, Frederik De Buck2,6, Steven Dymarkowski2,4, Piet Claus1, Francois Carré3, Johan Van Cleemput1,2, Andre La Gerche1,7, Hein Heidbuchel8.   

Abstract

Aims: The distinction between left ventricular (LV) dilation with mildly reduced LV ejection fraction (EF) in response to regular endurance exercise training and an early cardiomyopathy is a frequently encountered and difficult clinical conundrum. We hypothesized that exercise rather than resting measures would provide better discrimination between physiological and pathological LV remodelling and that preserved exercise capacity does not exclude significant LV damage. Methods and results: We prospectively included 19 subjects with LVEF between 40 and 52%, comprising 10 ostensibly healthy endurance athletes (EA-healthy) and nine patients with dilated cardiomyopathy (DCM). In addition, we recruited five EAs with a region of subepicardial LV. Receiver operating characteristic fibrosis (EA-fibrosis). Cardiac magnetic resonance (CMR) imaging was performed at rest and during supine bicycle exercise. Invasive afterload measures were obtained to enable calculations of biventricular function relative to load (an estimate of contractility). In DCM and EA-fibrosis subjects there was diminished augmentation of LVEF (5 ± 6% vs. 4 ± 3% vs. 14 ± 3%; P = 0.001) and contractility [LV end-systolic pressure-volume ratio, LVESPVR; 1.4 (1.3-1.6) vs. 1.5 (1.3-1.6) vs. 1.8 (1.7-2.7); P < 0.001] during exercise relative to EA-healthy. Receiver-operator characteristic curves demonstrated that a cut-off value of 11.2% for ΔLVEF differentiated DCM and EA-fibrosis patients from EA-healthy [area under the curve (AUC) = 0.92, P < 0.001], whereas resting LVEF and VO2max were not predictive. The AUC value for LVESPVR ratio was similar to that of ΔLVEF. Conclusions: Functional cardiac evaluation during exercise is a promising tool in differentiating healthy athletes with borderline LVEF from those with an underlying cardiomyopathy. Excellent exercise capacity does not exclude significant LV damage.

Entities:  

Mesh:

Year:  2018        PMID: 29590340     DOI: 10.1093/ehjci/jey050

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  13 in total

Review 1.  Athlete's Heart: Diagnostic Challenges and Future Perspectives.

Authors:  Carlo De Innocentiis; Fabrizio Ricci; Mohammed Y Khanji; Nay Aung; Claudio Tana; Elvira Verrengia; Steffen E Petersen; Sabina Gallina
Journal:  Sports Med       Date:  2018-11       Impact factor: 11.136

2.  Comment on: "Athlete's Heart: Diagnostic Challenges and Future Perspectives".

Authors:  Wilfried Kindermann; Axel Urhausen; Jürgen Scharhag
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

Review 3.  Exercise cardiovascular magnetic resonance: development, current utility and future applications.

Authors:  Thomas P Craven; Connie W Tsao; Andre La Gerche; Orlando P Simonetti; John P Greenwood
Journal:  J Cardiovasc Magn Reson       Date:  2020-09-10       Impact factor: 5.364

4.  Exercise right ventricular ejection fraction predicts right ventricular contractile reserve.

Authors:  Catherine G Ireland; Rachel L Damico; Todd M Kolb; Stephen C Mathai; Monica Mukherjee; Stefan L Zimmerman; Ami A Shah; Fredrick M Wigley; Brian A Houston; Paul M Hassoun; David A Kass; Ryan J Tedford; Steven Hsu
Journal:  J Heart Lung Transplant       Date:  2021-02-17       Impact factor: 13.569

Review 5.  Speckle Tracking Echocardiography for the Assessment of the Athlete's Heart: Is It Ready for Daily Practice?

Authors:  Lynsey Forsythe; Keith George; David Oxborough
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-27

Review 6.  Left Ventricular Trabeculations in Athletes: Epiphenomenon or Phenotype of Disease?

Authors:  Mark Abela; Andrew D'Silva
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-10-26

Review 7.  The Role of Cardiovascular Magnetic Resonance in Sports Cardiology; Current Utility and Future Perspectives.

Authors:  Emmanuel Androulakis; Peter P Swoboda
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-31

8.  Advanced Imaging to Phenotype Patients With a Systemic Right Ventricle.

Authors:  Frederik Helsen; Piet Claus; Alexander Van De Bruaene; Guido Claessen; André La Gerche; Pieter De Meester; Mathias Claeys; Charlien Gabriels; Thibault Petit; Béatrice Santens; Els Troost; Jens-Uwe Voigt; Jan Bogaert; Werner Budts
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

Review 9.  The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview.

Authors:  Stephen Foulkes; Guido Claessen; Erin J Howden; Robin M Daly; Steve F Fraser; Andre La Gerche
Journal:  Front Cardiovasc Med       Date:  2020-03-10

10.  Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension.

Authors:  Shareen Jaijee; Marina Quinlan; Pawel Tokarczuk; Matthew Clemence; Luke S G E Howard; J Simon R Gibbs; Declan P O'Regan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.